Avapro Blood Pressure Drug Does Not Help Heart Failure Patients

Boston (dbTechno) - A new clinical trial has shown that the blood pressure drug Avapro was not effective at helping heart failure patients in any way.

The drug Avapro is sold by both Bristol-Myers Squibb Co. as well as Sanofi-Aventis.

The drug is often used to help treat patients who have high blood pressure, as well as kidney problems.

This helps patients with prevention of heart disease, as well as type 2 diabetes.

It works by keeping blood vessels from getting narrow, and also enhances blood flow.

A new clinical trial carried out by researchers from the University of Texas School of Public Health found that it did not, however, help heart failure patients.

The study was done with 4,100 patients in 25 countries to see if it could help people who were having trouble pumping blood to their heart.

This type of heart failure, or preserved ejection fraction, takes place in 50% of patients with heart failure.

The results were disappointing though, as there was no added benefit for those who took the Avapro drug.